Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer
4
×
indiana blog main
indiana top stories
life sciences
national blog main
national top stories
san francisco blog main
4
×
san francisco top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
national
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer immunotherapy
celgene
clinical trials
eli lilly
genentech
investing
ipo
johnson & johnson
pfizer
sanofi
What
latest
4
×
companies
drug
address
alzheimer’s
american
annual
approval
approves
ash
bio
biotechs
blood
blueprint
borne
cancer
cancers
carries
certain
club
conference
continued
crop
designed
diego
different
exceeded
fail
fda
firms
gathering
gene
genetic
group
guide
haul
hematology
host
increases
ipo
Language
unset
Current search:
latest
×
cancer
×
" san francisco blog main "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M